Acute Ischemic Stroke Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Acute Ischemic Stroke Clinical Trials Market Report Overview
The Acute Ischemic Stroke clinical trial market research report provides an overview of the Acute Ischemic Stroke clinical trials scenario. The report provides top-line data relating to the clinical trials on Acute Ischemic Stroke. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Acute Ischemic Stroke Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Acute Ischemic Stroke clinical trials market are Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America, among others. Asia-Pacific dominated the market in November 2022.
In a country-wise analysis, as of November 2022, China has the highest number of Acute Ischemic Stroke clinical trials, followed by the US, Japan, Spain, Germany, South Korea, the UK, Australia, Canada, and France.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, France has the highest proportion of Acute Ischemic Stroke to Cardiovascular clinical trials as of November 2022. Moreover, the majority of the clinical trials were conducted in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Indonesia has the highest proportion of Acute Ischemic Stroke to Cardiovascular clinical trials as of November 2022. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
Acute Ischemic Stroke Clinical Trials Analysis by Regions
For more regional insights into the Acute Ischemic Stroke clinical trials market, download a free report sample
Acute Ischemic Stroke Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Acute Ischemic Stroke clinical trials market are institution, company, and the government. Out of them, institution dominates the market.
Acute Ischemic Stroke Clinical Trials Market Analysis by Sponsor Types
For more sponsor type insights into the Acute Ischemic Stroke clinical trials market, download a free report sample
Acute Ischemic Stroke Clinical Trials Market - Competitive Landscape
The leading sponsors in the Acute Ischemic Stroke clinical trials market are C. H. Boehringer Sohn AG & Co KG, Daiichi Sankyo Co Ltd, Bristol-Myers Squibb Co, Johnson & Johnson, Mitsubishi Chemical Group Corp, AstraZeneca Plc, F. Hoffmann-La Roche Ltd, CSPC Pharmaceutical Group Ltd, D-Pharm Ltd, and Guangzhou Magpie Pharmaceutical Co Ltd. Out of them, C. H. Boehringer Sohn AG & Co KG has conducted the highest number of Acute Ischemic Stroke clinical trials.
Acute Ischemic Stroke Clinical Trials Market Analysis by Sponsors
To know more about the leading players in the Acute Ischemic Stroke clinical trials market, download a free report sample
Acute Ischemic Stroke Clinical Trials Market Report Overview
Key Regions | Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America |
Key Countries | China, the US, Japan, Spain, Germany, South Korea, the UK, Australia, Canada, and France |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | C. H. Boehringer Sohn AG & Co KG, Daiichi Sankyo Co Ltd, Bristol-Myers Squibb Co, Johnson & Johnson, Mitsubishi Chemical Group Corp, AstraZeneca Plc, F. Hoffmann-La Roche Ltd, CSPC Pharmaceutical Group Ltd, D-Pharm Ltd, and Guangzhou Magpie Pharmaceutical Co Ltd |
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Daiichi Sankyo Co Ltd
Bristol-Myers Squibb Co
Johnson & Johnson
Mitsubishi Chemical Group Corp
AstraZeneca Plc
F. Hoffmann-La Roche Ltd
CSPC Pharmaceutical Group Ltd
D-Pharm Ltd
Guangzhou Magpie Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key regions in the Acute Ischemic Stroke clinical trials market?
The key regions in the Acute Ischemic Stroke clinical trials market are Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America, among others.
-
What are the key countries in the Acute Ischemic Stroke clinical trials market?
The key countries in the Acute Ischemic Stroke clinical trials market are China, the US, Japan, Spain, Germany, South Korea, the UK, Australia, Canada, and France.
-
What are the key sponsor types in the Acute Ischemic Stroke clinical trials market?
The key sponsor types in the Acute Ischemic Stroke clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the Acute Ischemic Stroke clinical trials market?
The leading sponsors in the Acute Ischemic Stroke clinical trials market are C. H. Boehringer Sohn AG & Co KG, Daiichi Sankyo Co Ltd, Bristol-Myers Squibb Co, Johnson & Johnson, Mitsubishi Chemical Group Corp, AstraZeneca Plc, F. Hoffmann-La Roche Ltd, CSPC Pharmaceutical Group Ltd, D-Pharm Ltd, and Guangzhou Magpie Pharmaceutical Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.